Charles DeCarli, head of the Alzheimer’s Disease Research Center at UC Davis, faced abrupt funding cuts from the NIH for a dementia study due to its focus on diversity, equity, and inclusion. This study examines vascular risk factors affecting dementia in minority groups, and the termination notice cited non-scientific categorization as the reason. Amidst turmoil over canceled appointments and pending blood samples, an appeal successfully reinstated the nearly $36 million in grants necessary to continue the research, highlighting both the vulnerabilities and resilience in scientific funding amid shifting political landscapes.
As the director of the University of California, Davis's federally funded Alzheimer's Disease Research Center, DeCarli studies vascular risk factors contributing to dementia cases.
The NIH's letter stated that the study's work was terminated because it no longer effectuates agency priorities due to its basis in artificial and non-scientific categories.
Collection
[
|
...
]